Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow$3.1B in Q3 2026 · $6.0B over twelve months
Operating cash flow$4.5B
Capital spending−$1.4B
Free cash flow+$3.1B
Cash / net income2.4×
Analysis
In Q3 2026, HCA Healthcare generated $4.5B of operating cash flow and spent $1.4B on capital projects, leaving free cash flow of $3.1B. That is $24.0M less than in Q3 2025 ($3.1B).
Over the twelve months to Sep 30, 2026, operating cash flow was $11.2B; the largest uses were buybacks ($9.2B), capital spending ($5.2B), other investing ($1.1B); besides operations, cash came from net borrowing (+) / repaid (−) ($5.8B), asset & business sales ($199M); the cash balance fell by $89.0M.
Operating cash flow was $4.5B against net income of $1.8B — 2.4× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$954M, receivables +$782M, payables +$769M.
Free cash flow
Operating cash flow less capital spending.Latest (Q3 2026): Operating cash flow $4.5B, Capital spending $1.4B.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $50.1B; the largest uses were buybacks ($35.1B) and capital spending ($22.5B). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$908M
Debt$44.8B
Net debt$43.9B
HCA Healthcare funds itself: free cash flow was $6.0B over the last twelve months, and $908M of cash and investments stands against $44.8B of debt.
Principal due in each year as disclosed in the annual report, against $908M of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Every quarter
Quarter
Operating cash flow
Capital spending
Buybacks
Dividends
Net borrowing (+) / repaid (−)
Cash drawn (+) / kept (−)
Free cash flow
Q3 2026
$4.5B
−$1.4B
−$3.0B
−$165M
$723M
$105M
$3.1B
Q2 2026
$2.3B
−$1.2B
−$2.1B
−$171M
$1.7B
−$73.0M
$1.1B
Q1 2026
$2.0B
−$1.1B
−$1.6B
−$183M
$1.4B
$100M
$895M
Q4 2025
$2.4B
−$1.5B
−$2.6B
−$162M
$2.0B
−$43.0M
$870M
Q3 2025
$4.4B
−$1.3B
−$2.5B
−$166M
−$36.0M
−$58.0M
$3.1B
Q2 2025
$4.2B
−$1.2B
−$2.5B
−$171M
−$217M
$121M
$3.0B
Q1 2025
$1.7B
−$991M
−$2.5B
−$180M
$1.6B
$873M
$660M
Q4 2024
$2.6B
−$1.3B
−$1.7B
−$165M
−$64.0M
$955M
$1.3B
HCA Healthcare: income statement and cash flow
HCA Healthcare, Q3 2026: revenue $19.8B (+4% year over year), operating margin 11.9%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.